UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study

Molecular psychiatry, 2013-03, Vol.18 (3), p.332-339

2013

Volltextzugriff (PDF)

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Molecular psychiatry, 2016-10, Vol.21 (10), p.1372-1380

2016

Volltextzugriff (PDF)

Lithium tremor revisited: pathophysiology and treatment

Acta psychiatrica Scandinavica, 2014-01, Vol.129 (1), p.17-23

2014

Volltextzugriff (PDF)

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder

Acta psychiatrica Scandinavica, 2016-02, Vol.133 (2), p.144-153

2016

Volltextzugriff (PDF)

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Molecular psychiatry, 2016-10, Vol.21 (10), p.1483-1484

2016

Volltextzugriff (PDF)

Adjunctive zonisamide for treatment refractory anxiety

International journal of clinical practice (Esher), 2007-06, Vol.61 (6), p.1050-1053

2007

Volltextzugriff (PDF)

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review

Progress in neuro-psychopharmacology & biological psychiatry, 2009-03, Vol.33 (2), p.169-180

2009

Volltextzugriff (PDF)

P.4.c.002 Quetiapine augmentation of SSRIs for treatment refractory social anxiety disorder

European neuropsychopharmacology, 2007, Vol.17, p.S517-S518

2007

Volltextzugriff (PDF)

P.4.a.012 Adjunctive levetiracetam for treatment refractory post-traumatic stress disorder (PTSD)

European neuropsychopharmacology, 2008, Vol.18, p.S484-S485

2008

Volltextzugriff (PDF)

Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder

The journal of clinical psychiatry, 2005-10, Vol.66 (10), p.1326-1330

2005

Volltextzugriff (PDF)

Olanzapine Augmentation of Fluoxetine for Refractory Generalized Anxiety Disorder: A Placebo Controlled Study

Biological psychiatry (1969), 2006-02, Vol.59 (3), p.211-215

2006

Volltextzugriff (PDF)

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

International clinical psychopharmacology, 2005-01, Vol.20 (1), p.9-11

2005

Volltextzugriff (PDF)

Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia

European psychiatry, 2007-03, Vol.22, p.S238-S239

2007

Volltextzugriff (PDF)

Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Molecular psychiatry, 2016, Vol.21 (10), p.1483-1484

2016

Volltextzugriff (PDF)

Levetiracetam for treatment-refractory posttraumatic stress disorder

The journal of clinical psychiatry, 2006-02, Vol.67 (2), p.211-214

2006

Volltextzugriff (PDF)

An open-label trial of risperidone augmentation for refractory anxiety disorders

The journal of clinical psychiatry, 2006-03, Vol.67 (3), p.381-385

2006

Volltextzugriff (PDF)

Anxiety disorders in women: does gender matter to treatment?

Revista brasileira de psiquiatria, 2005-10, Vol.27 Suppl 2 (suppl 2), p.S43-s50

2005

Volltextzugriff (PDF)

Mental Disorders in Subjects with Diabetes: A Systematic Review

Health care. Current reviews, 2017, Vol.5 (4)

2017

Volltextzugriff (PDF)

An open-label study of levetiracetam for the treatment of social anxiety disorder

The journal of clinical psychiatry, 2004-09, Vol.65 (9), p.1219

2004

Volltextzugriff (PDF)

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

Depression and anxiety, 2006, Vol.23 (3), p.178-181

2006

Volltextzugriff (PDF)

Valproic acid for the treatment of social anxiety disorder

International clinical psychopharmacology, 2003-05, Vol.18 (3), p.169-172

2003

Volltextzugriff (PDF)

SHORT COMMUNICATION: Adjunctive zonisamide for treatment refractory anxiety

International journal of clinical practice (Esher), 2007-06, Vol.61 (6), p.1050

2007

Volltextzugriff (PDF)

Adjunctive zonisamide for treatment refractory anxiety: Adjunctive zonisamide for refractory anxiety

International journal of clinical practice (Esher), 2007-06, Vol.61 (6), p.1050-1053

2007

Volltextzugriff (PDF)

Biological effects of levetiracetam in patients with generalized anxiety disorder: An MRS study

The international journal of neuropsychopharmacology, 2008-07, Vol.11, p.278

2008

Volltextzugriff (PDF)

Hypomania associated with omega3 fatty acids

Archives of general psychiatry, 2000-07, Vol.57 (7), p.715-716

Kinrys, G

2000

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Thema

Psychiatry
(35)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Humans
(30)
Female
(26)
Adult
(24)
Male
(22)
Middle Aged
(19)
Bipolar Disorder
(15)
Neurosciences & Neurology
(15)
Treatment Outcome
(15)
Antipsychotic Agents - Therapeutic Use
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Psychology. Psychoanalysis. Psychiatry
(12)
Clinical Neurology
(11)
Neuropharmacology
(11)
Pharmacology. Drug Treatments
(11)
Severity Of Illness Index
(11)
Adult And Adolescent Clinical Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Lithium tremor revisited: pathophysiology and treatment

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder

A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Adjunctive zonisamide for treatment refractory anxiety

Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review

P.4.c.002 Quetiapine augmentation of SSRIs for treatment refractory social anxiety disorder

P.4.a.012 Adjunctive levetiracetam for treatment refractory post-traumatic stress disorder (PTSD)

Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorder

Olanzapine Augmentation of Fluoxetine for Refractory Generalized Anxiety Disorder: A Placebo Controlled Study

Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

Evaluation of eszopiclone and escitalopram oxalate co-therapy in patients with generalized anxiety disorder and insomnia

Erratum: A Phase 1B, randomized, double blind, placebo controlled, multiple-dose escalation study of NSI-189 phosphate, a neurogenic compound, in depressed patients

Levetiracetam for treatment-refractory posttraumatic stress disorder

An open-label trial of risperidone augmentation for refractory anxiety disorders

Anxiety disorders in women: does gender matter to treatment?

Mental Disorders in Subjects with Diabetes: A Systematic Review

An open-label study of levetiracetam for the treatment of social anxiety disorder

The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

Valproic acid for the treatment of social anxiety disorder

SHORT COMMUNICATION: Adjunctive zonisamide for treatment refractory anxiety

Adjunctive zonisamide for treatment refractory anxiety: Adjunctive zonisamide for refractory anxiety

Biological effects of levetiracetam in patients with generalized anxiety disorder: An MRS study

Hypomania associated with omega3 fatty acids

Suchergebnisse filtern